Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1Genitourinary 1CNS 1Breast 1

Conditions

Ovarian Neoplasms 364Endometrial Neoplasms 209Uterine Cervical Neoplasms 194Breast Neoplasms 111Fallopian Tube Neoplasms 96Colorectal Neoplasms 83Carcinoma, Non-Small-Cell Lung 77Neoplasms 68Pancreatic Neoplasms 59Stomach Neoplasms 55Neoplasm Metastasis 51Prostatic Neoplasms 50Lung Neoplasms 47Melanoma 44Carcinoma, Ovarian Epithelial 41Triple Negative Breast Neoplasms 38Squamous Cell Carcinoma of Head and Neck 36Esophageal Neoplasms 35Carcinoma, Renal Cell 35Colonic Neoplasms 32Urinary Bladder Neoplasms 30Peritoneal Neoplasms 29Head and Neck Neoplasms 28Uterine Neoplasms 27Vulvar Neoplasms 26Carcinoma, Hepatocellular 26Carcinoma, Transitional Cell 24Small Cell Lung Carcinoma 23Sarcoma 20Rectal Neoplasms 19

Interventions

TP protocol 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm Recurrence, Local × Gynecologic × 90 days × Clear all
NCT06532539 2026-04-24

Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma

Shandong Cancer Hospital and Institute

Phase 2 Recruiting
30 enrolled
Gynecologic

Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡